| Financial Year |
March 31 2023 |
| Monetary Funds |
54,040,918.82 |
| Held-for-trading Financial Assets |
108,276,966.41 |
| Notes Receivable |
136,759,147.32 |
| Accounts Receivable |
41,507,642.24 |
| Advances to Suppliers |
8,221,208.07 |
| Other Receivables |
6,998,846.83 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
167,069,188.09 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
27,166,263.08 |
| Total Current Assets |
570,385,788.14 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
4,002,552.75 |
| Fixed Assetes |
734,195,000.22 |
| Under-construction Projects |
519,692,269.96 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
50,432,093.31 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
298,581.83 |
| Deferred Income Tax Assets |
151,597.74 |
| Other Non-Current Assets |
2,508,762.50 |
| Sub-Total of Non-Current Assets |
1,325,788,002.73 |
| Total Assets |
1,896,173,790.87 |
| Short-Term Loans |
9,871,163.12 |
| Trading Financial liabilities |
-- |
| Notes Payable |
6,552,600.82 |
| Accounts Payable |
158,713,262.93 |
| Accounts Received In Advance |
5,108,714.91 |
| Employee Compensation Payable |
13,008,050.14 |
| Taxes Payable |
5,960,933.99 |
| Interest Payable |
-- |
| Dividend Payable |
4,621,854.97 |
| Other payables |
195,054,614.91 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
3,867,731.41 |
| Other Current Liabilities |
69,248,233.24 |
| Sub-Total of Current Liabilities |
478,280,218.01 |
| Long-term Loans |
209,140,338.99 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
50,059,174.35 |
| Other Non-Current Liabilities |
59,724,565.10 |
| Sub-Total of Non-Current Liabilities |
331,781,716.94 |
| Total Liabilities |
810,061,934.95 |
| Paid-In Capital(Or Share Stock) |
366,346,010.00 |
| Capital Surplus |
537,525,468.24 |
| Surplus Reserve |
243,390,665.37 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
-154,348,836.06 |
| Minority Stockholder's Interest |
75,781,034.43 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
1,010,330,821.49 |
| Owner's Equity（Stockholder's Equity） |
1,086,111,855.92 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
1,896,173,790.87 |
